Clinetic, a Durham, North Carolina-based healthtech company focused on streamlining clinical research, announced that it closed Series A financing.
The round was led by Sopris Capital, a venture capital firm focused on technology-enabled healthcare solutions.
The financing will enable Clinetic to accelerate its patient recruitment and real-world data capabilities, deepen the company's relationships with its network of data-connected health systems, and support collaborations with a growing number of life science customers.
The Clinetic platform simplifies and accelerates patient recruitment for clinical studies by empowering health systems to securely harness the potential of their electronic health record (EHR) data and patient relationships. The platform also enables researchers to surface deep, timely clinical insights for real-world data studies.
"We are thrilled to partner with an investor who shares our vision for modernizing clinical research," said Tom Kaminski, co-founder and chief executive officer, Clinetic. "Our data-driven software platform streamlines highly manual activities for both health systems and life science companies to ultimately complete studies faster and advance new therapies to improve patient care.”
Company: Clinetic, Inc.
Round: Series A
Funding Month: August 2023
Lead Investors: Sopris Capital
Company Website: https://www.clinetic.com/
Software Category: EHR Data Analysis Platform
About the Company: Clinetic is a health technology company harnessing the potential of electronic health record (EHR) data to accelerate clinical research and evidence generation. They enable a growing network of health systems to efficiently identify and activate patients for clinical research through EHR-connected workflows. This helps complete studies faster with increased visibility, ultimately advancing new therapies to improve patient care.